drug · antibody
patient view →talquetamab
Marketedupdated 2mo agoby $JNJ JOHNSON & JOHNSON🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple myeloma and neoplasm.
targets
G-protein coupled receptor family C group 5 member DT cell surface glycoprotein CD3
all catalysts(8)
approval · 8
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that